Related Experiment Video

Updated: May 31, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Immunotherapy in prostate cancer: emerging strategies against a formidable foe

Marijo Bilusic1, Christopher Heery, Ravi A Madan

  • 1Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Vaccine
|July 12, 2011
PubMed

Insights

Therapeutic cancer vaccines show promise for prostate cancer treatment, stimulating the immune system to target cancer cells. Combination therapies are being explored to enhance vaccine effectiveness and patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Therapeutic vaccines represent a promising treatment approach for prostate cancer.
  • Unlike preventive vaccines, therapeutic vaccines activate the immune system against cancer-associated proteins.
  • Research is exploring combinations of vaccines with standard treatments like chemotherapy and radiation.

Purpose of the Study:

  • To review the current status and potential of therapeutic vaccines in prostate cancer treatment.
  • To highlight recent clinical trial findings and FDA-approved therapies.
  • To discuss the role of immune-based therapies in managing prostate and other cancers.

Main Methods:

  • Review of recent clinical trials involving therapeutic cancer vaccines.
  • Analysis of data from late-phase and randomized multicenter trials.
  • Examination of combination strategies with conventional cancer therapies.

Main Results:

  • Therapeutic vaccines demonstrate clinical benefit and maintain patient quality of life.
  • Sipuleucel-T is FDA-approved for metastatic prostate cancer treatment.
  • PSA-TRICOM shows promise in early- and late-stage prostate cancer trials.

Conclusions:

  • Immune-based therapies, including therapeutic vaccines, are emerging as significant treatment options for prostate cancer.
  • Combination strategies may optimize vaccine efficacy.
  • Therapeutic vaccines hold potential for treating various malignancies beyond prostate cancer.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...